TwoStep Therapeutics has filed a notice of an exempt offering of securities to raise $6,500,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, TwoStep Therapeutics is raising up to $6,500,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Caitlyn Miller played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About TwoStep Therapeutics
TwoStep Therapeutics is a venture-backed early-stage biotech startup developing novel tumor-targeting therapeutics for solid tumors.
To learn more about TwoStep Therapeutics, visit http://www.twosteptx.com/
Contact:
Caitlyn Miller, Chief Executive Officer
423-774-6778
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.